SHY Therapeutics LLC has a total of 23 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are GUANGZHOU INNOCARE PHARMA TECH CO LTD, G D SEARLE & CO CORPORATE PATE and ZHU ZHAONING.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Singapore | 2 | |
#9 | Canada | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Microorganisms | |
#5 | Medical preparations | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Carta Luca | 21 |
#2 | Schmertzler Michael | 21 |
#3 | Reynolds Charles H | 19 |
#4 | Hadari Yaron R | 19 |
#5 | Williams Theresa M | 19 |
#6 | Hutcheson Rebecca | 13 |
#7 | Charles H Reynolds | 2 |
#8 | Williams Theresa | 2 |
#9 | Michael Schmertzler | 2 |
#10 | Reynolds Charles | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020132071A1 | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease | |
AU2018288841A1 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease | |
AU2016378723A1 | Compounds for the treatment of cancer and inflammatory disease |